0 Commentarii
0 Distribuiri
733 Views
0 previzualizare
Căutare
Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni
-
Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
-
Radiation Oncology Market Expansion Through Digital Healthcare IntegrationThe global Radiation Oncology Market was valued at USD 14.0 billion in 2025 and is projected to grow from USD 15.5 billion in 2026 to USD 33.1 billion by 2033, registering a CAGR of 11.4% from 2026 to 2033. North America accounted for the largest revenue share of 46.2% in 2025, driven by the increasing prevalence of cancer, continuous technological advancements, and growing demand for...0 Commentarii 0 Distribuiri 324 Views 0 previzualizare
-
(R)-N-Boc-3-(Aminomethyl)Pyrrolidine Market 2026–2034: Chiral Pharmaceutical Intermediates Driving CNS, Oncology, and Antiviral Drug Development(R)-N-Boc-3-(Aminomethyl)Pyrrolidine market was valued at USD 28.4 million in 2025 and is projected to reach USD 58.2 million by 2034, exhibiting a remarkable CAGR of 7.4% during the forecast period. (R)-N-Boc-3-(Aminomethyl)Pyrrolidine is a specialized chiral pyrrolidine derivative featuring a tert-butoxycarbonyl (Boc) protecting group and an aminomethyl substituent at the 3-position....0 Commentarii 0 Distribuiri 983 Views 0 previzualizare
-
(R)-N-Boc-3-(Aminomethyl)Pyrrolidine Market 2026–2034: Chiral Pharmaceutical Intermediates Driving CNS, Oncology, and Antiviral Drug Development(R)-N-Boc-3-(Aminomethyl)Pyrrolidine market was valued at USD 28.4 million in 2025 and is projected to reach USD 58.2 million by 2034, exhibiting a remarkable CAGR of 7.4% during the forecast period. (R)-N-Boc-3-(Aminomethyl)Pyrrolidine is a specialized chiral pyrrolidine derivative featuring a tert-butoxycarbonyl (Boc) protecting group and an aminomethyl substituent at the 3-position....0 Commentarii 0 Distribuiri 1K Views 0 previzualizare
-
Immuno-Oncology (I-O) Market Witnesses Rapid Growth in Monoclonal Antibody TherapiesMonoclonal Antibodies Cancer Therapy Revolutionizing Modern Oncology Monoclonal antibodies cancer therapy has become one of the most effective advancements in cancer treatment. These therapies use laboratory-engineered antibodies to identify and attack cancer cells with high precision. Unlike conventional chemotherapy, which can damage both healthy and cancerous cells, monoclonal antibodies...0 Commentarii 0 Distribuiri 903 Views 0 previzualizare
-
Oncology Information Systems Market Outlook Through 2033The global Oncology Information Systems Market is witnessing significant growth as healthcare providers increasingly adopt advanced digital solutions to improve cancer diagnosis, treatment planning, and patient management. The market size was estimated at USD 3.2 billion in 2025 and is projected to reach USD 6.0 billion by 2033, growing at a CAGR of 8.3% from 2026 to 2033. The...0 Commentarii 0 Distribuiri 908 Views 0 previzualizare
-
Radiopharmaceuticals Market Witnesses Strong Growth in Precision Oncology TreatmentsTherapeutic Radiopharmaceuticals: Transforming Cancer Treatment Through Precision Nuclear Medicine Therapeutic radiopharmaceuticals represent one of the most innovative advancements in modern oncology, offering highly targeted treatment options that deliver radioactive isotopes directly to diseased cells. These therapies are designed to destroy cancer cells while minimizing damage to...0 Commentarii 0 Distribuiri 915 Views 0 previzualizare
-
Radiopharmaceuticals Market Witnesses Strong Growth in Precision Oncology TreatmentsTherapeutic Radiopharmaceuticals: Transforming Cancer Treatment Through Precision Nuclear Medicine Therapeutic radiopharmaceuticals represent one of the most innovative advancements in modern oncology, offering highly targeted treatment options that deliver radioactive isotopes directly to diseased cells. These therapies are designed to destroy cancer cells while minimizing damage to...0 Commentarii 0 Distribuiri 957 Views 0 previzualizare
-
[ Latest Report ] Non-Oncology Precision Medicine Market Share, Growth by Business Developments 2025 to 2032Non-Oncology Precision Medicine Market Summary “The global Non-Oncology Precision Medicine Market is expected to reach to USD 57.3 billion by 2032, growing at a CAGR of 5.7% during 2025 to 2032” The TrendBridge Insights Research report, “Global Non-Oncology Precision Medicine Market Report 2025 – Future Opportunities, Latest Trends, In-depth Analysis, and Forecast...0 Commentarii 0 Distribuiri 2K Views 0 previzualizare
-
Cancer Immunotherapy Market Emerging Trends and Technology InnovationsThe global Cancer Immunotherapy Market was valued at USD 153.3 billion in 2025 and is projected to grow from USD 166.4 billion in 2026 to USD 305.8 billion by 2033, registering a CAGR of 9.0% from 2026 to 2033. North America dominated the global market with the largest revenue share of 43.3% in 2025, primarily driven by the increasing prevalence of cancer, continuous innovation in...0 Commentarii 0 Distribuiri 128 Views 0 previzualizare
-
Dasatinib Market Developments in Tyrosine Kinase Inhibitor TreatmentsThe global Dasatinib Market was valued at USD 5.6 billion in 2025 and is projected to reach USD 7.6 billion by 2033, expanding at a CAGR of 4.3% from 2026 to 2033. The market is witnessing steady growth due to the increasing prevalence of hematologic cancers, particularly Chronic Myeloid Leukemia (CML) and Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL)....0 Commentarii 0 Distribuiri 543 Views 0 previzualizare
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Portuguese (Brazil)
Greek